HCC Risk in Hepatitis C Stage-3 Fibrosis After SVR With DAAs HCC Risk in Hepatitis C Stage-3 Fibrosis After SVR With DAAs
Do patients with chronic hepatitis C and stage 3 fibrosis remain at risk of hepatocellular carcinoma even after sustained virological response with DAAs?Liver International
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Surgery | Urology & Nephrology | Virology